In the present study, we investigated the presence and frequency of three non-synonymous P2Y2 gene polymorphisms in a Dutch cohort of fracture patients and analyzed whether genetic variation in this purinergic receptor was associated with altered BMD, i.e., osteoporosis risk. Here, P2RY2 is linked to osteoporosis.